V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008523 | 260005692 | 1.81 | 102 | null | 2013-04-03 | 2013-04-10 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260028078 | BENDAMUSTINE |
| 260008524 | 260005692 | 1.74 | 76.8 | Curative (C) | 2015-09-01 | 2015-09-11 | Rituximab | 02 | N | 260028078 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 260008525 | 260005693 | 1.55 | 67 | Palliative (P) | 2018-02-02 | 2018-02-08 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260028083 | RITUXIMAB |
| 260008526 | 260005694 | 1.65 | 70.6 | Curative (C) | 2016-01-15 | 2016-01-15 | Rituximab (SUBCUTANEOUS Maintenance) | null | Y | 260028084 | RITUXIMAB |
| 260008527 | 260005694 | 1.78 | 74.6 | Disease modification (D) | 2014-03-21 | 2014-04-03 | PACIFICO TRIAL | 2 | N | 260028084 | CAPECITABINE + OXALIPLATIN |
| 260008528 | 260005694 | null | 88.1 | Curative (C) | 2016-05-30 | 2016-06-03 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260028084 | BENDAMUSTINE |
| 260008529 | 260005695 | 1.9 | null | Curative (C) | 2019-02-02 | 2019-02-23 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260028091 | ENZALUTAMIDE |
| 260008530 | 260005696 | null | 64.5 | Palliative (P) | 2015-12-25 | 2016-01-05 | CHOP - 21 days | N | N | 260028095 | RITUXIMAB |
| 260008531 | 260011945 | 1.8 | 64 | Disease modification (D) | 2016-10-23 | 2016-10-25 | Rituximab | 02 | N | 260028097 | RITUXIMAB |
| 260008532 | 260011945 | 1.71 | 90.4 | Curative (C) | 2016-12-20 | 2017-01-19 | CHLORAMBUCIL + RITUXIMAB | N | N | 260028097 | RITUXIMAB |
| 260008533 | 260005697 | 1.8 | null | Disease modification (D) | 2016-04-27 | 2016-05-08 | Rituximab | N | N | 260028100 | RITUXIMAB |
| 260008534 | 260005697 | 1.83 | 165 | Adjuvant (A) | 2017-03-14 | 2017-04-05 | EOX | N | N | 260028100 | RITUXIMAB |
| 260008535 | 260005698 | 1.77 | 75.8 | Curative (C) | 2014-07-21 | 2014-07-21 | DA-EPOCH-R | 2 | N | 260028105 | CHLORAMBUCIL + RITUXIMAB |
| 260008536 | 260005698 | 1.8 | 75 | Curative (C) | null | 2017-10-14 | Rituximab | N | N | 260028105 | PACIFICO TRIAL |
| 260008537 | 260005699 | 1.68 | 104 | Curative (C) | 2015-10-21 | 2018-04-20 | Rituximab (Maintenance) | N | N | 260028108 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008538 | 260005699 | 1.55 | null | Not known (9) | 2016-09-26 | 2016-10-03 | R Chlorambucil | 02 | N | 260028108 | RITUXIMAB |
| 260008539 | 260005699 | null | 72.25 | Adjuvant (A) | 2015-05-22 | 2015-05-27 | Rituximab | 02 | N | 260028108 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008540 | 260005700 | 1.55 | 74.6 | Disease modification (D) | 2017-04-05 | 2017-04-06 | PACIFICO TRIAL | 02 | N | 260028113 | RITUXIMAB |
| 260008541 | 260005700 | 1.78 | 65.65 | null | 2015-06-14 | 2015-06-18 | Cisplatin + Etoposide (5 day) | 2 | N | 260028113 | CISPLATIN + ETOPOSIDE |
| 260008542 | 260005701 | 1.74 | 72 | Curative (C) | 2014-09-16 | 2014-09-18 | PACIFICO TRIAL | 02 | N | 260028118 | RITUXIMAB |
| 260008543 | 260005702 | 1.72 | 95.6 | Curative (C) | 2014-11-19 | 2014-11-20 | CISPLATIN + ETOPOSIDE | N | N | 260028119 | PACIFICO TRIAL |
| 260008544 | 260005702 | null | 73 | Palliative (P) | 2018-01-17 | 2018-02-16 | Rituximab (Maintenance) | null | N | 260028119 | BENDAMUSTINE |
| 260008545 | 260005703 | null | 95.2 | Palliative (P) | 2013-11-08 | 2013-11-09 | CVP | 02 | N | 260028126 | CYTARABINE HIGH DOSE |
| 260008546 | 260005704 | 1.78 | 114.6 | Curative (C) | 2018-01-10 | 2018-01-19 | Capecitabine + Oxaliplatin 21day | N | N | 260028129 | OXALIPLATIN + MDG |
| 260008547 | 260005704 | 1.65 | 81.2 | Curative (C) | null | 2016-05-06 | Rituximab (Maintenance) | null | null | 260028129 | DOCETAXEL |
| 260008550 | 260005706 | 1.62 | null | Disease modification (D) | 2012-01-25 | 2015-03-14 | PMitCEBO | 02 | N | 260028137 | CISPLATIN + RT |
| 260008551 | 260005707 | 1.73 | 86.7 | null | 2013-12-27 | 2013-12-27 | Rituximab | 02 | null | 260028139 | FCR |
| 260008552 | 260005707 | null | null | null | 2018-02-02 | 2018-02-02 | Rituximab | N | N | 260028139 | RITUXIMAB |
| 260008553 | 260005708 | 1.67 | 86 | Curative (C) | 2017-03-15 | 2017-03-15 | CYCLO + RITUXIMAB + VINCRISTINE | 2 | N | 260028143 | ABVD |
| 260008554 | 260005709 | 0 | 49.7 | Curative (C) | null | 2019-02-21 | BOP | Y | N | 260028144 | NOT MATCHED |
| 260008555 | 260005709 | 1.71 | 67.35 | Disease modification (D) | 2014-05-01 | 2014-05-13 | Rituximab | 02 | N | 260028144 | RITUXIMAB |
| 260008556 | 260005710 | 1.73 | 59.4 | Adjuvant (A) | 2013-07-27 | 2013-07-27 | Bendamustine + prednisolone | N | N | 260028155 | R-CHOEP |
| 260008557 | 260005711 | 1.6 | 81 | Curative (C) | 2017-10-14 | 2017-10-15 | Rituximab (Maintenance) | 02 | Y | 260028156 | PACIFICO TRIAL |
| 260008558 | 260005711 | 1.8 | 66.4 | Disease modification (D) | 2014-11-30 | 2014-11-30 | Rituximab | Y | N | 260028156 | CYCLOPHOSPHAMIDE |
| 260008559 | 260005712 | 1.86 | null | Curative (C) | 2018-01-09 | 2018-01-20 | Rituximab | N | N | 260028158 | TIP |
| 260008560 | 260005713 | 1.76 | 57 | null | 2015-09-11 | 2015-09-11 | Rituximab | N | N | 260028161 | RITUXIMAB |
| 260008561 | 260005713 | 1.85 | null | Palliative (P) | 2016-01-11 | 2016-01-11 | Rituximab | 02 | N | 260028161 | RITUXIMAB |
| 260008562 | 260005713 | null | 80.9 | Curative (C) | 2014-11-27 | 2014-12-04 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | null | 260028161 | CISPLATIN + ETOPOSIDE |
| 260008563 | 260017399 | 1.72 | 53.2 | null | 2017-07-15 | 2017-07-30 | Rituximab | 1 | null | 260028168 | CHOP |
| 260008564 | 260005714 | 1.59 | 79.5 | Radical (R) | 2016-02-25 | 2016-02-25 | Chlorambucil | N | N | 260028169 | CODOX M |
| 260008565 | 260005714 | 1.83 | 88 | Palliative (P) | 2017-11-11 | 2017-11-17 | Trial Unspecified | N | N | 260028169 | ENZALUTAMIDE |
| 260008567 | 260005716 | 1.8 | 75 | Disease modification (D) | 2013-10-02 | 2013-11-06 | Rituximab | N | N | 260028176 | RITUXIMAB |
| 260008568 | 260011958 | 0 | 70.7 | Disease modification (D) | 2013-04-30 | 2013-06-02 | Chlorambucil | N | N | 260028182 | CAPECITABINE + CISPLATIN |
| 260008569 | 260005717 | null | 69.3 | null | null | 2018-05-05 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 260028183 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008570 | 260005717 | 1.82 | 87.8 | Curative (C) | 2015-03-03 | 2015-03-04 | Cisplatin + Etoposide (5 day) | 2 | null | 260028183 | EP |
| 260008571 | 260005718 | null | 74 | null | 2016-06-28 | 2016-07-05 | Rituximab | N | N | 260028187 | CARBOPLATIN + ETOPOSIDE |
| 260008573 | 260005720 | 1.71 | 83.6 | Palliative (P) | 2016-09-04 | 2016-09-11 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260028193 | AZACITIDINE |
| 260008574 | 260005720 | 1.62 | 86.15 | Curative (C) | null | 2018-09-22 | Rituximab | N | N | 260028193 | FLUOROURACIL + MITOMYCIN + RT |
| 260008575 | 260005720 | 1.57 | 94.1 | Neo-adjuvant (N) | 2014-02-18 | 2014-02-19 | Rituximab | 2 | N | 260028193 | RITUXIMAB |
| 260008576 | 260005721 | null | 110 | Adjuvant (A) | 2017-05-12 | 2017-05-12 | Imatinib 400mg | N | N | 260028197 | CHOP |